FR2900936B1 - Procede et methodes de detection de la maladie d'alzheimer - Google Patents

Procede et methodes de detection de la maladie d'alzheimer

Info

Publication number
FR2900936B1
FR2900936B1 FR0604294A FR0604294A FR2900936B1 FR 2900936 B1 FR2900936 B1 FR 2900936B1 FR 0604294 A FR0604294 A FR 0604294A FR 0604294 A FR0604294 A FR 0604294A FR 2900936 B1 FR2900936 B1 FR 2900936B1
Authority
FR
France
Prior art keywords
disease
alzheimer
methods
mammals
way
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0604294A
Other languages
English (en)
Other versions
FR2900936A1 (fr
Inventor
Fabien Schweighoffer
Laurent Bracco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIAXONIT
Original Assignee
ExonHit Therapeutics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0604294A priority Critical patent/FR2900936B1/fr
Application filed by ExonHit Therapeutics SA filed Critical ExonHit Therapeutics SA
Priority to EP07766039A priority patent/EP2021509A2/fr
Priority to AU2007251408A priority patent/AU2007251408B2/en
Priority to JP2009510510A priority patent/JP2009537133A/ja
Priority to US12/227,374 priority patent/US20100055682A1/en
Priority to NZ573505A priority patent/NZ573505A/en
Priority to KR1020087030380A priority patent/KR20090098941A/ko
Priority to PCT/FR2007/051263 priority patent/WO2007132120A2/fr
Priority to CN2007800267862A priority patent/CN101490280B/zh
Priority to CA002652258A priority patent/CA2652258A1/fr
Publication of FR2900936A1 publication Critical patent/FR2900936A1/fr
Priority to IL195288A priority patent/IL195288A/en
Priority to ZA200810528A priority patent/ZA200810528B/xx
Priority to FR1261064A priority patent/FR2980484A1/fr
Application granted granted Critical
Publication of FR2900936B1 publication Critical patent/FR2900936B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Plant Pathology (AREA)
  • Psychiatry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
FR0604294A 2006-05-15 2006-05-15 Procede et methodes de detection de la maladie d'alzheimer Expired - Fee Related FR2900936B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0604294A FR2900936B1 (fr) 2006-05-15 2006-05-15 Procede et methodes de detection de la maladie d'alzheimer
PCT/FR2007/051263 WO2007132120A2 (fr) 2006-05-15 2007-05-14 Procede et methodes de detection de la maladie d'alzheimer
JP2009510510A JP2009537133A (ja) 2006-05-15 2007-05-14 アルツハイマー病を検出するための手順および方法
US12/227,374 US20100055682A1 (en) 2006-05-15 2007-05-14 Procedure and methods for detecting alzheimers's disease
NZ573505A NZ573505A (en) 2006-05-15 2007-05-14 Procedure and methods for detecting alzheimer's disease
KR1020087030380A KR20090098941A (ko) 2006-05-15 2007-05-14 알츠하이머 질환의 검출 절차 및 방법
EP07766039A EP2021509A2 (fr) 2006-05-15 2007-05-14 Procédé et méthodes de détection de la maladie d'alzheimer
CN2007800267862A CN101490280B (zh) 2006-05-15 2007-05-14 检测阿尔茨海默病的试剂
CA002652258A CA2652258A1 (fr) 2006-05-15 2007-05-14 Procede et methodes de detection de la maladie d'alzheimer
AU2007251408A AU2007251408B2 (en) 2006-05-15 2007-05-14 Procedure and methods for detecting Alzheimer's disease
IL195288A IL195288A (en) 2006-05-15 2008-11-13 Methods for identifying Alzheimer's disease
ZA200810528A ZA200810528B (en) 2006-05-15 2008-12-11 Procedure and methods for detecting Alzheimer's disease
FR1261064A FR2980484A1 (fr) 2006-05-15 2012-11-21 Procede et methodes de detection de la maladie d'alzheimer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0604294A FR2900936B1 (fr) 2006-05-15 2006-05-15 Procede et methodes de detection de la maladie d'alzheimer

Publications (2)

Publication Number Publication Date
FR2900936A1 FR2900936A1 (fr) 2007-11-16
FR2900936B1 true FR2900936B1 (fr) 2013-01-04

Family

ID=37496633

Family Applications (2)

Application Number Title Priority Date Filing Date
FR0604294A Expired - Fee Related FR2900936B1 (fr) 2006-05-15 2006-05-15 Procede et methodes de detection de la maladie d'alzheimer
FR1261064A Withdrawn FR2980484A1 (fr) 2006-05-15 2012-11-21 Procede et methodes de detection de la maladie d'alzheimer

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR1261064A Withdrawn FR2980484A1 (fr) 2006-05-15 2012-11-21 Procede et methodes de detection de la maladie d'alzheimer

Country Status (12)

Country Link
US (1) US20100055682A1 (fr)
EP (1) EP2021509A2 (fr)
JP (1) JP2009537133A (fr)
KR (1) KR20090098941A (fr)
CN (1) CN101490280B (fr)
AU (1) AU2007251408B2 (fr)
CA (1) CA2652258A1 (fr)
FR (2) FR2900936B1 (fr)
IL (1) IL195288A (fr)
NZ (1) NZ573505A (fr)
WO (1) WO2007132120A2 (fr)
ZA (1) ZA200810528B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2929292A1 (fr) * 2008-03-28 2009-10-02 Exonhit Therapeutics S A Sa Procede et methodes de diagnostic de la maladie d'alzheimer
ES2628944T3 (es) 2008-05-23 2017-08-04 Mochida Pharmaceutical Co., Ltd. Método para la evaluación de la función de fagocitos
US20100099609A1 (en) * 2008-07-28 2010-04-22 Buck Institute For Age Research eAPP AND DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE
KR101295019B1 (ko) * 2011-04-22 2013-08-09 경북대학교 산학협력단 리포칼린 2 수준을 측정하는 것을 포함하는 경도 인지 장애 진단용 조성물, 키트 및 경도인지 장애 진단을 위한 정보 제공방법.
US9541561B2 (en) 2012-06-14 2017-01-10 Electronics And Telecommunications Research Institute Method for diagnosing Alzheimer's disease using biomaterial
EP2728015A1 (fr) * 2012-10-31 2014-05-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Procédé pour le diagnostic du syndrome de Sézary
WO2016024101A1 (fr) * 2014-08-13 2016-02-18 Timmons James Archibald Diagnostic médical
CN104328200B (zh) * 2014-11-18 2016-04-06 宁波大学 辅助诊断阿尔茨海默病的检测试剂盒及其检测方法
US20200199645A1 (en) * 2017-09-08 2020-06-25 Control Of Innate Immunity Technology Research Association Device and method for diagnosis of alzheimer's symptoms
EP4376824A4 (fr) * 2021-07-27 2025-05-07 The Hong Kong University of Science and Technology Compositions et méthodes de traitement de la maladie d'alzheimer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0791660A1 (fr) * 1996-02-22 1997-08-27 Smithkline Beecham Corporation Nouveau marqueur diagnostique pour variations d'épissage de gènes en association avec fonctions neurologiques
DE60123431D1 (de) * 2000-07-25 2006-11-09 Sir Mortimer B Davis Jewish Ge Ho-1 suppressor als diagnostischer und prognostischer test für demenz-krankheiten
CA2474689A1 (fr) * 2002-01-31 2003-08-07 Celestar Lexico-Sciences, Inc. Medicaments ameliorant les troubles du rythme circadien
CA2480671A1 (fr) * 2002-03-29 2003-10-23 Celestar Lexico-Sciences, Inc. Inhibiteurs de phosphorylation c-jun
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof
GB0227238D0 (en) * 2002-11-21 2002-12-31 Diagenic As Product and method

Also Published As

Publication number Publication date
ZA200810528B (en) 2009-10-28
US20100055682A1 (en) 2010-03-04
KR20090098941A (ko) 2009-09-18
WO2007132120A3 (fr) 2008-05-08
IL195288A (en) 2013-10-31
AU2007251408A1 (en) 2007-11-22
WO2007132120A2 (fr) 2007-11-22
NZ573505A (en) 2011-04-29
CN101490280B (zh) 2012-09-26
FR2980484A1 (fr) 2013-03-29
AU2007251408B2 (en) 2012-11-29
FR2900936A1 (fr) 2007-11-16
IL195288A0 (en) 2009-08-03
EP2021509A2 (fr) 2009-02-11
JP2009537133A (ja) 2009-10-29
CN101490280A (zh) 2009-07-22
CA2652258A1 (fr) 2007-11-22

Similar Documents

Publication Publication Date Title
WO2007132120A3 (fr) Procede et methodes de detection de la maladie d'alzheimer
WO2009144424A3 (fr) Procede et methodes de diagnostic de la maladie d'alzheimer
WO2008021290A3 (fr) Protéines spécifiques d'organes et procédés d'utilisation
WO2007114947A3 (fr) Système et procédés hautement sensibles destinés à une analyse de la troponine
WO2009058902A3 (fr) Procédés et dispositifs pour une détection d'analyte
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
WO2008070865A3 (fr) Matériaux et méthodes pour détecter efficacement et précisément des analytes
ATE452343T1 (de) Verbesserte vitamin-d-messung
WO2006128192A3 (fr) Utilisation d'adn en circulation libre pour le diagnostic, le pronostic et le traitement du cancer
EP2021794B8 (fr) Utilisation de la protéine s100a 12 en tant que marqueur du cancer du côlon et du rectum
WO2009074983A3 (fr) Analyse permettant de détecter les acides nucléiques libres en circulation
WO2002086448A3 (fr) Detection de l'instabilite des microsatellites et son utilisation dans le diagnostic des tumeurs
WO2007114986A3 (fr) Sondes coopératives et leurs procédés d'utilisation
WO2007048978A3 (fr) Procede de detection du cancer
WO2009019370A3 (fr) Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal
WO2008020823A3 (fr) Systèmes de rapporteur coopératifs, composants, et procédés pour une détection d'analyte
EP2269065A4 (fr) Procédés et réactifs pour augmenter la sensibilité d'une détection métallographique par enzyme
BRPI0809958C1 (pt) conjunto de esferas para a detecção de uma cepa de hpv e/ou para diferenciação entre duas ou mais cepas de hpv, método para a preparação do referido conjunto de esferas, método para o diagnóstico de infecção por hpv, método para determinação do risco de um indivíduo humano desenvolver uma doença associada a uma ou mais cepas de hpv e par de iniciadores para amplificação de oligonucleotídeo direcionado ao hpv oncogênico
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
WO2011109112A3 (fr) Procédé de détection de la protéine tau et des fragments de tau dans le sérum
WO2008131261A3 (fr) Biomarqueurs peptidiques de maladie cardiovasculaire
EP1891108A4 (fr) Réactifs et dosages diagnostiques permettant de détecter la protéine psp94
WO2007030949A3 (fr) Procedes de diagnostic de cancer des ovaires et necessaires a cet effet
WO2011012691A3 (fr) Processus et procédés de diagnostic de la maladie d'alzheimer

Legal Events

Date Code Title Description
CD Change of name or company name
CD Change of name or company name

Owner name: DIAXONIT

Effective date: 20131203

ST Notification of lapse

Effective date: 20150130